Outcomes after Blinatumomab Failure in Patients with Relapsed/ Refractory (R/R) B-cell ALL (ALL)

The outcome of patients with R/R ALL post blinatumomab failure has not been thoroughly studied. Understanding the prognosis of the patients may guide clinicians to develop better treatment strategies.

Source: Clinical Lymphoma, Myeloma and Leukemia - August 26, 2016 Category: Hematology Authors: Musa Yilmaz, Hagop Kantarjian, Deborah Thomas, Tapan Kadia, Guillermo Garcia-Manero, Rita Khouri, Farhad Ravandi, Gautam Borthakur, Jorge Cortes, Alessandra Ferrajoli, Koji Sasaki, Jane Autry, Rebecca Garris, Kelsey Voit, Susan O ’Brien, Elias Jabbour Source Type: research